课题基金 / 基金详情

HYPOXIA MARKERS WITH CELL PROLIFERATION MARKERS IN HUMAN TUMORS

HYPOXIA MARKERS WITH CELL PROLIFERATION MARKERS IN HUMAN TUMORS
人类肿瘤中的缺氧标记与细胞增殖标记
批准号：
5217925
负责人：
MAHESH A VARIA
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5217925
关键词：
biomarker clinical research human subject human therapy evaluation hypoxia neoplasm /cancer radiation therapy neoplastic growth radiosensitizer

项目摘要

项目成果

MAHESH A VARIA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The current proposal utilizing Pimonidazole represents another step in the ongoing hypoxia marker studies, similar to our previous protocol CRU 767 describing the use of misonidazole as a tumor hypoxia marker. Over a 2 year period we anticipate entering 25 patients, 18 years or older in this study. Pimonidazole will be administered intravenously.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HYPOXIA MARKERS WITH CELL PROLIFERATION MARKERS IN HUMAN TUMORS
Correlative Study of Tumor Hypoxia and Metastatic Potential in Breast Cancer
Hypoxia Markers with Cell Proliferation Markers in Human Tumors
HYPOXIA MARKERS WITH CELL PROLIFERATION MARKERS IN HUMAN TUMORS
海外基金